Inogen INGN
NASDAQ INGN
$5.61 -0.07 (-1.14%)
At close: Aug 20, 2026 · 2:29 PM UTC

Inogen (INGN) Total Debt Growth (1y) (2014 - 2016)

Inogen (INGN) Total Debt Growth (1y) (2014 - 2016) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn 142.67%
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn -9.88%
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn -1.95%
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn 1,188.16%
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn 0.12%
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn -17.79%
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -9.03%
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn -0.50%
10 Inogen 151.86 Mn 46.32 Mn 43.27 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2016 -79.54%
Jun 30, 2016 -65.88%
Mar 31, 2016 -55.93%
Dec 31, 2015 -48.70%
Sep 30, 2015 -40.58%
Jun 30, 2015 -97.73%
Mar 31, 2015 -94.12%
Dec 31, 2014 -94.23%